(877) 363-6376

HELPLINE

NEWS

Clinical Trials

Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different clinical trial areas: immune checkpoint blockades, targeted therapies, anti-angiogenesis, and viral and neoantigen therapies. 

These sessions are presented by:
Marjorie Zauderer, MD, Westchester Medical Center
Melina Marmarelis, MD, University of Pennsylvania

This is a recording of a session at the 2024 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Merck; The Gori Law Firm; Bristol Myers Squibb; Early Lucarelli Sweeney & Meisenkothen

Find other recorded sessions and more information at www.curemeso.org/symposium

Also...

In Other News

Peritoneal Panel

2026 International Symposium for Malignant Mesothelioma | October 23, 2026 | The Woodlands, Texas Joel Baumgartner, MD Hedy Kindler, MD Mecker Moller, MD Kanwal Raghav,

Read More »

Legal Panel

2026 International Symposium for Malignant Mesothelioma | October 23, 2026 | The Woodlands, Texas Moderated by: Cheryl Bruner This panel discussion brings together experienced attorneys

Read More »

Share:

Facebook
Twitter
LinkedIn